Astelin® Nasal Spray Provided Greater Improvement in Relieving Nasal Allergy Symptoms Than Zyrtec®

Posted by Administrator on February 24th, 2006 — in Zyrtec Top News

new head-to-head, peer-reviewed clinical trial demonstrated that ASTELIN® Nasal Spray™ (azelastine HCl), marketed by MedPointe Pharmaceuticals, provided 25 percent greater reduction in nasal symptoms than top-selling prescription antihistamine Zyrtec (cetirizine HCl), marketed by Pfizer Inc. The new data, published in the May 2005 issue of Clinical Therapeutics, also showed that ASTELIN offered significantly greater […]

No Comments »

FDA approves generic Flonase

Posted by Administrator on February 24th, 2006 — in Zyrtec Top News

WASHINGTON - Regulators approved the first generic version of Flonase on Wednesday, touting the move in a rare press release and conference call with reporters as one that should provide users of the allergy drug a cheaper alternative.
Fluticasone Propionate Nasal Spray is the first generic version of Flonase, which has annual sales of more than […]

No Comments »